Using Therapeutic Value Ratings to Bolster Illegal Drug Marketing Allegations
October 16, 2017
Whistleblowers seeking to expose pharmaceutical fraud including kickbacks and other deceptive marketing practices, such as misrepresentation of a drug’s benefits, may wish to bolster their allegations with any available evidence that the illegally promoted drug lacks therapeutic benefit, relying on rankings assigned by entities such as the Patented Medicine Prices Review Board and Prescrire International. Evidence of lack of therapeutic...